Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 105.20
-0.10 (-0.09%)
Feb 16, 2026, 12:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 96.9 billion as of February 13, 2026. Its market cap has increased by 72.46% in one year.
Market Cap
96.90B
Enterprise Value
93.97B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
105.20
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 96.90B, an increase of 422.56%. That is a compound annual growth rate of 32.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 96.90B | -6.90% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 299.38B |
| WuXi Biologics | 167.57B |
| Innovent Biologics | 154.61B |
| Sino Biopharmaceutical | 116.73B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.21B |
| 3SBio | 58.99B |
| RemeGen | 56.94B |
| Shanghai Henlius Biotech | 38.32B |